A Cell Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States

Researchers employed a systems biology approach and identified a core-regulatory circuit that plays the primary role in driving complete epithelial-to-mesenchymal transition reversal without hybrid properties.